Financhill
Sell
24

STRR Quote, Financials, Valuation and Earnings

Last price:
$2.08
Seasonality move :
9.1%
Day range:
$2.08 - $2.21
52-week range:
$2.08 - $5.55
Dividend yield:
0%
P/E ratio:
0.70x
P/S ratio:
0.13x
P/B ratio:
0.18x
Volume:
19.8K
Avg. volume:
12.7K
1-year change:
-60%
Market cap:
$6.7M
Revenue:
$45.8M
EPS (TTM):
-$3.08
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $72.9M $78.2M $106.6M $57.1M $45.8M
Revenue Growth (YoY) -29.99% 7.17% 36.33% -46.37% -19.89%
 
Cost of Revenues $55.8M $64.2M $91.3M $44.8M $33.9M
Gross Profit $17.2M $14M $15.2M $12.4M $11.9M
Gross Profit Margin 23.53% 17.9% 14.3% 21.65% 26.05%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $15.9M $18.6M $22.6M $14.2M $14.5M
Other Inc / (Exp) -$2.6M $2.9M $1.1M -$1.3M $852K
Operating Expenses $16.7M $20.8M $24.3M $15.9M $16.3M
Operating Income $433K -$6.8M -$9.1M -$3.5M -$4.3M
 
Net Interest Expenses $746K $1.3M $905K $564K --
EBT. Incl. Unusual Items -$2.9M -$5.2M -$8.9M -$5.4M -$2.5M
Earnings of Discontinued Ops. -$1.9M -$1.2M $5.9M $575K $27M
Income Tax Expense -$199K $129K $60K $383K -$614K
Net Income to Company -$5M -$6.5M -$8.1M -$5.3M $25.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.6M -$6.5M -$3M -$5.3M $25.1M
 
Basic EPS (Cont. Ops) -$12.80 -$11.45 -$4.80 -$2.45 $7.40
Diluted EPS (Cont. Ops) -$12.80 -$11.45 -$4.80 -$2.45 $7.35
Weighted Average Basic Share $408.2K $731.8K $1M $3M $3.1M
Weighted Average Diluted Share $408.2K $731.8K $1M $3M $3.2M
 
EBITDA $5.9M $5.6M -$4.5M -$9K -$1.7M
EBIT -$2.2M -$3.9M -$8M -$3.5M -$4.3M
 
Revenue (Reported) $72.9M $78.2M $106.6M $57.1M $45.8M
Operating Income (Reported) $433K -$6.8M -$9.1M -$3.5M -$4.3M
Operating Income (Adjusted) -$2.2M -$3.9M -$8M -$3.5M -$4.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $21.3M $28.9M $11.1M $10.4M $13.7M
Revenue Growth (YoY) -24.76% 35.37% -61.51% -6.05% 30.93%
 
Cost of Revenues $17.6M $25.1M $8M $8.2M $10.8M
Gross Profit $3.7M $3.7M $3.1M $2.2M $2.8M
Gross Profit Margin 17.26% 12.98% 27.68% 21.11% 20.62%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.5M $5.2M $3.1M $3.4M $7.4M
Other Inc / (Exp) $135K $3K -$713K -$965K $3.3M
Operating Expenses $5.1M $5.6M $3.5M $3.9M $8.1M
Operating Income -$1.4M -$1.9M -$452K -$1.7M -$5.3M
 
Net Interest Expenses $309K $260K $120K -- --
EBT. Incl. Unusual Items -$1.6M -$2.1M -$1.3M -$2.2M -$2M
Earnings of Discontinued Ops. -$166K -- -$898K -$257K --
Income Tax Expense $11K -- -$299K $172K -$18K
Net Income to Company -$1.8M $3M -$1.9M -$2.6M -$2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.8M -$2.1M -$1.9M -$2.6M -$2M
 
Basic EPS (Cont. Ops) -$2.35 -$2.55 -$0.60 -$0.84 -$0.61
Diluted EPS (Cont. Ops) -$2.35 -$2.55 -$0.60 -$0.99 -$0.78
Weighted Average Basic Share $944.8K $1M $3.1M $3.1M $3.2M
Weighted Average Diluted Share $944.8K $1M $3.1M $3.1M $3.2M
 
EBITDA $1.1M -$1M $425K -$1.1M -$4.3M
EBIT -$1.3M -$1.9M -$452K -$1.7M -$5.3M
 
Revenue (Reported) $21.3M $28.9M $11.1M $10.4M $13.7M
Operating Income (Reported) -$1.4M -$1.9M -$452K -$1.7M -$5.3M
Operating Income (Adjusted) -$1.3M -$1.9M -$452K -$1.7M -$5.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $49.9M $100.2M $82.5M $49.3M $50.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $36.8M $87.9M $65.4M $34.8M $40.9M
Gross Profit $13.1M $12.2M $17.1M $14.5M $9.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.3M $21.4M $19.8M $15.5M $20.1M
Other Inc / (Exp) $986K $7M -$5.1M -$685K $4.7M
Operating Expenses $15.9M $23.1M $21.6M $17.3M $22.3M
Operating Income -$2.8M -$10.9M -$4.5M -$2.8M -$12.8M
 
Net Interest Expenses $1M $1M $637K -- --
EBT. Incl. Unusual Items -$2.8M -$4.9M -$10.2M -$3.1M -$7M
Earnings of Discontinued Ops. -$3.4M $6M -$1.2M $28.1M -$80K
Income Tax Expense $41K $91K $167K -$245K -$869K
Net Income to Company -$6.3M $978K -$16.7M $25.3M -$6.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.3M $978K -$11.6M $25.3M -$6.3M
 
Basic EPS (Cont. Ops) -$15.70 -$0.75 -$7.55 $7.69 -$2.91
Diluted EPS (Cont. Ops) -$15.70 -$0.75 -$7.55 $7.54 -$3.08
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $7.8M $967K -$4.9M $128K -$9.7M
EBIT -$1.8M -$3.9M -$8.4M -$2.8M -$12.8M
 
Revenue (Reported) $49.9M $100.2M $82.5M $49.3M $50.4M
Operating Income (Reported) -$2.8M -$10.9M -$4.5M -$2.8M -$12.8M
Operating Income (Adjusted) -$1.8M -$3.9M -$8.4M -$2.8M -$12.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $55M $77M $53M $31.7M $36.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $44.9M $68.7M $42.8M $22.6M $29.7M
Gross Profit $10.1M $8.3M $10.2M $9.1M $6.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $13.1M $15.8M $13.1M $11.3M $16.8M
Other Inc / (Exp) $967K $5.1M -$1.2M -$506K $3.4M
Operating Expenses $14.8M $17.1M $14.4M $12.6M $18.6M
Operating Income -$4.7M -$8.8M -$4.2M -$3.5M -$12M
 
Net Interest Expenses $1M $731K $464K $27K --
EBT. Incl. Unusual Items -$4.7M -$4.5M -$5.8M -$3.5M -$8M
Earnings of Discontinued Ops. -$1.2M $6M -$1.2M $27.1M --
Income Tax Expense $72K $34K $141K $233K -$22K
Net Income to Company -$6M $1.4M -$7.2M $23.4M -$8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6M $1.4M -$7.2M $23.4M -$8M
 
Basic EPS (Cont. Ops) -$13.60 $0.20 -$2.90 $7.24 -$2.80
Diluted EPS (Cont. Ops) -$13.60 $0.20 -$2.90 $7.09 -$2.97
Weighted Average Basic Share $2M $3M $8.7M $9.3M $9.6M
Weighted Average Diluted Share $2M $3M $8.7M $9.3M $9.6M
 
EBITDA $3.5M -$1.1M -$1.6M -$1.5M -$9.5M
EBIT -$3.7M -$3.8M -$4.2M -$3.5M -$12M
 
Revenue (Reported) $55M $77M $53M $31.7M $36.3M
Operating Income (Reported) -$4.7M -$8.8M -$4.2M -$3.5M -$12M
Operating Income (Adjusted) -$3.7M -$3.8M -$4.2M -$3.5M -$12M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.7M $3.2M $4.5M $4.4M $18.3M
Short Term Investments $26K -- $47K $3.5M $4.8M
Accounts Receivable, Net $12.9M $13M $15.8M $8M $6M
Inventory $7M $9.8M $8.5M $4.7M $3.4M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3M $2M $2M $682K $1.2M
Total Current Assets $29.5M $48.9M $31.9M $39.3M $34.8M
 
Property Plant And Equipment $12.5M $12.7M $13.4M $7.5M $9.3M
Long-Term Investments -- -- -- -- $6M
Goodwill $10M $9.5M $6M $4.4M $4.4M
Other Intangibles $19M $16.9M $15.1M $13.4M $12.5M
Other Long-Term Assets $19.5M $1.4M $1.7M $7.4M $9K
Total Assets $90.6M $89.5M $68.1M $73.3M $75.5M
 
Accounts Payable $6.5M $5M $4.3M $1.4M $1.6M
Accrued Expenses $2.9M $2.2M $2.5M $93K $983K
Current Portion Of Long-Term Debt $20.3M $18.4M $12.9M -- --
Current Portion Of Capital Lease Obligations $1.7M $1.9M $1.8M $454K $445K
Other Current Liabilities $4.5M $7.9M -- $18.3M --
Total Current Liabilities $44.5M $43M $27.8M $27.5M $8.7M
 
Long-Term Debt $740K $3.7M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $49.9M $49.5M $32.3M $31.5M $10.2M
 
Common Stock $19.6M $21.5M $19M $19M $19M
Other Common Equity Adj -- -- -- -- --
Common Equity $21.1M $18.4M $16.8M $22.8M $46.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $40.7M $39.9M $35.7M $41.8M $65.3M
 
Total Liabilities and Equity $90.6M $89.5M $68.1M $73.3M $75.5M
Cash and Short Terms $1.8M $3.2M $4.6M $7.9M $23.2M
Total Debt $23M $24.4M $12.9M $3.4M $2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $4.3M $5.6M $8.5M $20.7M $5.5M
Short Term Investments $31K -- $3.2M $4.3M $3.2M
Accounts Receivable, Net $15.8M $15.9M $13.8M $3.7M $6.5M
Inventory $9M $10M $13.1M $4.2M $5.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.4M $2.7M $3.1M $859K $1.5M
Total Current Assets $31.6M $34.3M $42.4M $34.6M $25.3M
 
Property Plant And Equipment $22.8M $12.8M $13.3M $6.8M $17.4M
Long-Term Investments -- -- -- $6M $3.9M
Goodwill $10M $9.4M $6M $4.4M $8.5M
Other Intangibles $20.5M $15.5M $13.8M $12.1M $19.7M
Other Long-Term Assets $1.2M $2.8M $1.4M $36K $2.3M
Total Assets $86M $74.9M $77M $72.3M $85.7M
 
Accounts Payable $7M $4.6M $6.1M $1.1M $1.7M
Accrued Expenses $237K $426K $4.6M $1.4M $3.3M
Current Portion Of Long-Term Debt $4.3M $1.1M $864K -- $1.8M
Current Portion Of Capital Lease Obligations $1.8M $1M $1.9M $449K $327K
Other Current Liabilities $3.4M $2.7M $635K $94K --
Total Current Liabilities $24.9M $29.6M $32.2M $6.8M $12.3M
 
Long-Term Debt $16.9M -- -- -- $7.8M
Capital Leases -- -- -- -- --
Total Liabilities $45.8M $33.6M $36.8M $8.3M $27.3M
 
Common Stock $21M $22M $19M $19M $21.6M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $40.2M $41.3M $40.2M $64M $58.4M
 
Total Liabilities and Equity $86M $74.9M $77M $72.3M $85.7M
Cash and Short Terms $4.3M $5.6M $11.7M $25M $8.7M
Total Debt $21.2M $14M $11.9M $537K $11.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$5M -$6.5M -$8.1M -$5.3M $25.1M
Depreciation & Amoritzation $8.1M $9.4M $3.5M $3.5M $2.7M
Stock-Based Compensation $540K $524K $527K $438K $340K
Change in Accounts Receivable -$3.3M $1.2M -$3.7M -$2.7M $3.7M
Change in Inventories -$30K -$2.6M $1.3M -$2.1M $1M
Cash From Operations $400K -$5M -$6.5M -$3.9M $2.7M
 
Capital Expenditures $6.7M $1.5M $788K $1.2M $698K
Cash Acquisitions -$1M -- -$300K -- -$2.8M
Cash From Investing -$5.8M -$1.3M $17.8M -$5.1M $16.2M
 
Dividends Paid (Ex Special Dividend) -- -- -$4.4M -$1.9M -$1.9M
Special Dividend Paid
Long-Term Debt Issued $98.5M $120.5M $117.6M $105.9M $41.2M
Long-Term Debt Repaid -$95.1M -$117.3M -$125.8M -$107.8M -$42.3M
Repurchase of Common Stock -$150K -- -- -- --
Other Financing Activities -$659K -$345K -$55K -$455K -$16K
Cash From Financing $5.7M $8.1M -$10M $8.9M -$3.1M
 
Beginning Cash (CF) $1.4M $2M $3.4M $3.9M $4.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $590K $1.4M $1.4M $591K $14.4M
Ending Cash (CF) $2M $3.4M $4.8M $4.5M $18.9M
 
Levered Free Cash Flow -$6.3M -$6.4M -$7.2M -$5M $2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.8M $3M -$1.9M -$2.6M -$2M
Depreciation & Amoritzation $2.4M $860K $877K $569K $1M
Stock-Based Compensation $122K $126K $106K $78K $58K
Change in Accounts Receivable -$1.2M -$1.8M $1.1M $468K -$245K
Change in Inventories -$1.3M $2M -$1.8M $194K $259K
Cash From Operations -$1.9M -$577K -$3.2M $804K $569K
 
Capital Expenditures $360K $292K $478K $359K $149K
Cash Acquisitions -- -- -- -- -$575K
Cash From Investing -$288K -$227K -$1.6M -$894K $6.5M
 
Dividends Paid (Ex Special Dividend) -- -$479K -$479K -$479K -$541K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $27.1M $27.7M $26.6M $2M -$4.8M
Long-Term Debt Repaid -$29.8M -$27M -$26.5M -$1.6M $1.5M
Repurchase of Common Stock -- -- -- -- -$218K
Other Financing Activities -$3K -- -$2K -$16K --
Cash From Financing -$2.6M $217K -$373K -$80K -$4M
 
Beginning Cash (CF) $9.3M $6.3M $14.1M $21.4M $4.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.2M -$588K -$5.4M -$169K $3M
Ending Cash (CF) $4.1M $5.7M $8.7M $21.3M $7.1M
 
Levered Free Cash Flow -$2.3M -$869K -$3.6M $445K $420K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$6.3M $978K -$16.7M $25.3M -$6.3M
Depreciation & Amoritzation $9.6M $4.9M $3.5M $2.9M $3.1M
Stock-Based Compensation $506K $533K $458K $400K $242K
Change in Accounts Receivable $905K -$4.8M $896K $1.4M -$1.4M
Change in Inventories -$684K -$1M -$3.1M $2.2M $2M
Cash From Operations -$715K -$11.2M $1.5M -$954K -$3.7M
 
Capital Expenditures $976K $1.5M $1.3M $525K $542K
Cash Acquisitions -- -- -- -- -$22.4M
Cash From Investing -$582K $17M -$5M $19.4M -$15.8M
 
Dividends Paid (Ex Special Dividend) -- -$958K -$4.9M -$1.9M -$2M
Special Dividend Paid
Long-Term Debt Issued $117.5M $126.1M $106.4M $61.8M $21.7M
Long-Term Debt Repaid -$118M -$129.8M -$109.3M -$64.7M -$14.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$547K -$58K -$464K -- --
Cash From Financing $4M -$4M $7.1M -$4.9M $5.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.8M $1.7M $3.8M $12.6M -$14.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.7M -$12.8M $147K -$1.5M -$4.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$6M $1.4M -$7.2M $23.4M -$8M
Depreciation & Amoritzation $7.2M $2.6M $2.7M $2.1M $2.5M
Stock-Based Compensation $382K $391K $322K $284K $186K
Change in Accounts Receivable $2.9M -$3.1M $1.5M $5.5M $359K
Change in Inventories -$1.7M -$193K -$4.5M -$246K $726K
Cash From Operations -$1.9M -$8.2M -$234K $2.7M -$3.7M
 
Capital Expenditures $646K $675K $1.2M $568K $412K
Cash Acquisitions -- -- -- -- -$19.7M
Cash From Investing -$490K $17.8M -$5M $19.5M -$12.5M
 
Dividends Paid (Ex Special Dividend) -- -$958K -$1.4M -$1.4M -$1.5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $85.6M $91.3M $80.1M $36M $16.5M
Long-Term Debt Repaid -$85.7M -$98.2M -$81.6M -$38.6M -$10.4M
Repurchase of Common Stock -- -- -- -- -$218K
Other Financing Activities -$333K -$46K -$455K -$16K --
Cash From Financing $4.7M -$7.3M $9.7M -$4.1M $4.3M
 
Beginning Cash (CF) $12.7M $23.1M $34.3M $31.1M $38.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.1M $2.3M $4.8M $16.7M -$11.9M
Ending Cash (CF) $14.8M $25.4M $38.2M $47.8M $26.4M
 
Levered Free Cash Flow -$2.5M -$8.9M -$1.5M $2.1M -$4.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock